SurModics (SRDX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Qualys (QLYS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Bank of America (BAC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck. How do you find the right combination ...

Carvana CVNA is a leading e-commerce platform for buying and selling used cars. The company’s near-term earnings outlook has ...

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 3rd: ...

Does International Consolidated Airlines Group SA (ICAGY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Here are four drug and biotech stocks, ARQT, MESO, MNPR and KOD, which have more than doubled in 2024 with room for further growth in 2025.

In the closing of the recent trading day, AppLovin (APP) stood at $344.82, denoting a +1.12% change from the preceding trading day.

ACM Research (ACMR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

TTM Technologies (TTMI) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates ...